20 May 2013
Keywords: bayer, looking, roche, otc, business, following, statements
Article | 09 February 2004
Following Roche's statements that its over-the-counter business (thought to be worth $1.6-2.4 billion) could be sold, Germany's Bayer is
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 February 2004
9 February 2004
© 2013 thepharmaletter.com